October 12, 2022
Company partners with leading distributors in the Gulf region and Israel as well as expands Asia Pacific coverage to Japan for sales, service and support of SYNTAX System instruments and kits SOUTH SAN FRANCISCO, Calif. & PARIS -- DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has signed distribution [...]
Agilent Opens Center of Excellence for Dissolution Products
October 12, 2022
SANTA CLARA, Calif. --- Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, quality, support, applications, marketing, and more. This investment allows all Agilent dissolution activities to [...]
908 Devices and CPI Improve mAbs Cell Culture Outcomes Using At-line Media Analysis
October 12, 2022
REBEL mass spec device used to reduce toxic metabolite accumulation while increasing cell viability and titer by up to 40% BOSTON -- 908 Devices (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biomolecular analysis, announced that its collaboration with CPI is demonstrating the value of at-line cell culture media analysis to inform feeding [...]
October 12, 2022
State College, PA – Gamma Biosciences, a leading provider of tools and technologies for cell and gene therapy manufacturing, through their BioMagnetic Solutions business, today announced a strategic collaboration with Lonza. Under the multi-year agreement, BioMagnetic Solutions will supply its proprietary research and cGMP manufacturing grade FerroSelect™ reagents to Lonza for use in developing CAR-T and other [...]
October 11, 2022
ONI’s Super-resolution Nanoimager will be used to identify predictive CAR-T biomarkers and characteristics related to treatment outcomes San Diego, CA and Oxford, UK – ONI, a single-molecule imaging platform biotech, today announced a research collaboration with the University of Pennsylvania, one of the true pioneers of CAR-T (chimeric antigen t-cell) research and clinical trials. The collaboration [...]
faCellitate Starts Marketing New 384-well Spheroid Microplate
October 11, 2022
(Mannheim) faCellitate expands its BIOFLOAT™ coated microplate portfolio by a 384 well format specifically designed for spheroid culture The exceptional performance of the BIOFLOAT™ coating combined with the high density 384-format makes the new product solution particularly valuable for high-throughput spheroid screening Accelerated assays due to spheroid culture without centrifugation and unique spheroid quality - experts call [...]
October 11, 2022
Aims to improve efficiency of pharma pipelines by leveraging industry-leading ability to identify genetic variants that contribute to human disease SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a strategic research collaboration with AstraZeneca, a global, science-led biopharmaceutical company, to accelerate drug target discovery by [...]
October 11, 2022
News Summary: New Extraction+™ Connected Device automates and documents SPE methods, shaving hours off sample preparation for biological, food, forensic, environmental, and clinical research applications. Waters OneLab™ Software guides users through the process of creating, optimizing and transferring sample preparation methods across different labs and users. Automated solution frees up scientists to perform other tasks, [...]
BIO-TECHNE INTRODUCES NEW SIMPLE PLEX AAV VIRAL TITER ASSAYS
October 11, 2022
Simple Plex AAV assays combine industry leading AAV antibody reagents from PROGEN with convenience and simplicity of the fully automated Ella platform. MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) and PROGEN announced today the release of three new Simple Plex™ Adeno-Associated Virus (AAV) viral titer assays for intact AAV capsid quantification. Featuring best-in-class AAV reagents from PROGEN—a leader [...]
Swedish innovation help to accelerate diagnosis of leukemia for children
October 11, 2022
- Qlucore's software is used in leading research projects Swedish Qlucore - a leader in precision diagnostics for the analysis of cancer - has played an important role in the Swedish-Danish collaboration iCOPE, which aims, among other things, to improve the treatment of children affected by acute leukemia. With diagnoses increasing by 6-10 percent a [...]

